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Mechanical stretch reveals dierent components of
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1 Since the role of mechanical stretches in vascular tone regulation is poorly understood, we
studied how stretch can influence endothelial tone.
2 Isometric contractions of isolated rat aortic helical strips were recorded. The resting tension was
set at 0.7 g, 1.2 g or 2.5 g. Endothelium-preserved strips were precontracted with either
phenylephrine or prostaglandin F2a (PGF2a).
3 In control conditions, acetylcholine (ACh) dose-dependently relaxed phenylephrine-precontracted
strips independently of resting tension.
4 At 0.7 g resting tension, nitric oxide synthase (NOS) inhibitors did not reduce ACh-induced
relaxation, while either a guanylyl cyclase inhibitor or a NO trapping agent prevented it. At 1.2 g
and 2.5 g resting tensions, NOS inhibitors shifted the ACh dose-response curve to the right.
5 After preincubation with indomethacin (5 mM) or ibuprofen (10 and 100 mM), at 0.7 g and 1.2 g
resting tensions, ACh induced an endothelium-dependent, dose-dependent contraction. ACh
(1076 M) increased the contraction up to two times greater the phenylephrine-induced one.
Lipoxygenase inhibitors prevented it. At high stretch, the ACh vasorelaxant eect was marginally
influenced by cyclooxygenase (COX) inhibition. Similar results were obtained when aortic strips
were precontracted with PGF2a.
6 Our data indicate that when resting tension is low, ACh mobilizes a stored NO pool that,
synergistically with COX-derived metabolites, can relax precontracted strips. COX inhibition up-
regulates the lipoxygenase metabolic pathway, accounting for the ACh contractile eect. At an
intermediate resting tension, NO production is present, but COX inhibition reveals a lipoxygenase-
dependent, ACh-induced contraction. At high resting tension, NO synthesis predominates and COX
metabolites influence ACh-induced relaxation marginally.
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Introduction
At least three dierent endothelial-derived relaxant factors
have been thus far identified: prostacyclin (PGI2), nitric oxide
(NO), and the endothelial-derived hyperpolarizing factor
(EDHF). PGI2 is the main metabolite of cyclooxygenase
(COX) in endothelial cells and its role as an anti-aggregating
agent is well defined (Moncada & Vane, 1979). It seems,
however, to aect vascular relaxation less, since in the
presence of indomethacin, endothelial cell activation can still
relax precontracted vascular preparations (Furchgott &
Zawadzki, 1980). NO is produced by endothelial constitutive
NO synthase (ecNOS) from L-arginine (Palmer et al., 1988).
Throughout guanylyl cyclase activation, guanosine 3’:5’-cyclic
monophosphate (cyclic GMP) increase and cyclic GMP-
dependent protein kinase stimulation, NO can induce smooth
muscle cell relaxation (Cornwell et al., 1991). EDHF has been
identified as a cytochrome P450 metabolite of arachidonic
acid (Fisslthaler et al., 1999), which, by activation of
potassium channels, can induce hyperpolarization of vascular
smooth muscle cell membrane and artery relaxation (Camp-
bell & Harder, 1999).
Depending on the experimental and pathophysiological
conditions, all these compounds can contribute to endothe-
lial-dependent vasorelaxation.
Moreover, endothelial cells also produce contractile
substances. Contracting factors include lipid-derived eicosa-
noids, such as arachidonic acid and lipoxygenase metabolites
(Ezra et al., 1983; Rimele & Vanhoutte, 1983; Berkowitz et
al., 1984; Marsault et al., 1997; Filipeanu et al., 1998).
Leukotrienes are also produced by endothelial cells in culture
(Ka¨hler et al., 1993; Hollenberg et al., 1994). Therefore, from
common precursor arachidonic acid, endothelial cells may
produce either vasorelaxant factors or vasocontracting
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substances according to the prevalence of the dierent
metabolic pathway.
Among the physiological regulators of endothelial-derived
vasoactive substance production, shear stress and cell stretch
may be of primary relevance. However, the influence of cell
stretch on endothelial-derived vasoactive substance produc-
tion and release is still partially unclear.
The eect of stretch has been investigated by Dainty et al.
(1990) by changing either the resting length or the resting
tension of rat aortic preparations in vitro. The authors show
that the initial length of preparation (and hence stretch
degrees) modifies the contractile response to phenylephrine.
The decrease in tone induced by 1 mM acetylcholine (ACh), is
indeed dependent on the initial stretch of endothelial-intact
preparations. Although the authors focused their analysis on
result variability from dierent laboratories, it emerged that
variations in arterial tone and stretch may influence the
response of smooth muscle cells to endothelial-derived
vasoactive factors.
In coronary preparations from guinea-pigs and rats, stretch
influences the relative contribution of endothelial-derived
vasorelaxant substances to smooth muscle cell hyperpolariza-
tion (Parkington et al., 1993). Indeed, in unstretched guinea-
pig coronary arteries, the hyperpolarization of smooth muscle
cells induced by ACh is only slightly reduced by co-
incubation with the ecNOS inhibitor o-nitro-L-arginine
methylester (L-NAME) and indomethacin. Indeed, exogenous
NO and PGI2 are without eect. In contrast, in stretched
preparations, exogenous NO and PGI2 induce hyperpolariza-
tion and co-incubation with L-NAME, and indomethacin
abolishes the slow component of ACh-induced hyperpolar-
ization. Delayed hyperpolarization is also induced by
arachidonic acid, and indomethacin is able to antagonize its
eect, suggesting that a metabolite of arachidonic acid may
account for this eect. Similar results are also obtained in rat
coronary arteries, although PGI2 is unable to induce
hyperpolarization (Parkington et al., 1993). These data
indicate that the contribution of dierent vasorelaxant
products may vary according to the resting tension.
Since the role of stretch in endothelial-derived vascular
tone regulation has been only partially explored, we decided
to investigate the ACh eect on contractile tone in rat aortic
strips stretched at dierent resting tensions. Our data indicate
that, according to stretch, the relative contribution of NO
and arachidonic acid metabolites on ACh-induced relaxation
varies. At low stretch, ACh can either relax or contract aortic
preparations, considering that relaxation is obtained when
COX products are present and contraction is obtained when
COX is inhibited. Moreover, in this condition a stored,
depletable NO pool is released independently of ecNOS
inhibition. At high stretch, NO relaxation predominates and
COX inhibition does not influence the ACh-induced relaxa-
tion.
Methods
This investigation conforms to European Community rules
for the care and use of laboratory animals.
Microscopy
Helical preparations of rat thoracic aorta were fixed by
immersion in 2.5% glutaraldehyde in 0.1 M cacodylate buer
(pH 7.4) for 6 h at room temperature, postfixed in 1% OsO4
in 0.1 M phosphate buer (pH 7.4) dehydrated in acetone
series, passed through propylene oxide, and embedded in
epoxy resin (Epon 812, Fluka, Buchs, Switzerland). Semithin
sections, 2 mm thick, were cut with an ultramicrotome,
stained with toluidine blue-sodium tetraborate, viewed and
photographed with a light microscope. Semithin sections were
used because they allow for a clear-cut identification of the
components of the arterial tunica intima, especially the
endothelium.
Functional studies
Male Wistar rats (300 – 350 g) were anaesthetized and killed
by cervical dislocation. Thoracic aortas between the aortic
arch and diaphragm were isolated and placed in cold
gassed (5% CO2 in O2) Krebs-Henseleit solution (K-H) of
the following composition (mM): NaCl 110, NaHCO3 25,
KCl 4.8, KH2PO4 1.2, MgSO4 1.2, D(+)glucose 11, CaCl2
2.5. The aorta was cleaned from adhering fat and
connective tissue and cut into helical strips (3 mm width,
20 mm length). The strips were mounted in an organ bath
(2 ml) with one end connected to a tissue holder and the
other to a force transducer (Battaglia-Rangoni), then the
strips were perfused with pre-warmed (378) K-H, gassed
with 5% CO2 in O2. The resting tension was set at 0.7, 1.2
or 2.5 g and the tissue was equilibrated for 60 min. These
resting tensions were arbitrarily chosen in the range in
which phenylephrine, prostaglandin F2a (PGF2a) and ACh
induced, in control conditions, a similar dose-response
curve (see below). Isometric contractions were recorded.
After equilibration, dose-response curves to phenylephrine
or PGF2a were performed and the maximal contraction
obtained was expressed as 100% of contractile response.
Using the maximal contracting dose of phenylephrine or
PGF2a (100%), the cumulative dose-response curve of ACh
was done. In several experiments, after extensive washing in
the absence (control) or presence of ecNOS inhibitors,
1077 M of phenylephrine was reapplied and the ACh dose-
response curve repeated. The complete procedure was
reproduced several times until a superimposable ACh
dose-response curve was obtained. All dose-response curves
were performed by administering drugs as a bolus injection.
In each preparation, the presence of a functional
endothelial lining was demonstrated in control conditions
by a near-complete relaxation to ACh of precontracted
strips. To further assess that the manipulation of aortic
preparations had not caused a loss of the endothelial layer,
light microscopic examination was carried out on aortic
helical strips prepared as for the functional experiments.
The relaxation or contraction induced by ACh was
expressed as a decrease or an increase in the contractile
force from the maximal contraction. Experiments were
mostly performed on endothelium-intact preparations. In
several cases, the endothelium was removed by rubbing the
cells with cotton gauze, and the absence of endothelium
was determined as described before, where ACh was unable
to induce relaxation.
6-keto prostaglandin F1a (6-keto PGF1a) release 6-keto
PGF1a was measured, using a commercial radioimmunoassay
kit (Amersham Pharmacia Biotech, Buckinghamshire, U.K.),
in the lyophilized perfusion medium obtained by closing the
organ bath for 4 min. Standard concentrations of 6-keto
PGF1a were also dissolved in K-H and lyophilized
analogously to unknown samples. Determinations were
carried out according to the instructions provided by the
manufacturer.
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Materials
Acetylcholine (ACh), phenylephrine, prostaglandin F2a
(PGF2a), indomethacin, ibuprofen sodium salt, 5,8,11-triynoic
acid (ETI), 2-phenyl-4,4,5-tetramethyl-imidazoline-1-oxyl-3-
oxide (PTIO), o-monomethyl-L-arginine monoacetate salt (L-
NMMA) and L-N5-(1-iminoethyl)ornithine dihydrochloride
(L-NIO) were obtained from Sigma Chemical Co. (St. Louis,
MO, U.S.A.), o-nitro-L-arginine methylester (L-NAME),
6-anilino-5,8-quinolinequinone (LY83583) were purchased
from Calbiochem (La Jolla, CA, U.S.A.). All other reagents
were of analytical grade. 3-(1-(4-chlorobenzyl)-3t-butyl-thio-5-
isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886)
was the kind gift of Merck Sharp & Dohme, Italy (Rome).
Mathematical and statistical methods
Statistical comparisons between data groups were performed
using paired Student’s t-test. Median eective concentrations
(EC50s) were calculated using the Implot (version4) program
(GraphPad Software, San Diego, CA, U.S.A.). A P value
50.05 was considered significant.
Results
Morphology
Histological examination of semithin sections of aortic strips
revealed the presence of large tracts of the aortic wall provided
with a continuous layer of endothelial cells (not shown).
Functional studies
Phenylephrine caused a rapid onset, dose-dependent contrac-
tion of aortic strips independent of the resting tension;
therefore, as shown in Figure 1, the dose-response curves
were superimposable, obtaining maximal contraction at
1077 M phenylephrine. Hence, in all experiments 1077 M
phenylephrine was used to precontract aortic strips.
In phenylephrine precontracted aortic strips, administra-
tion of ACh induced a dose-dependent relaxation (Figure 2,
panels A and B), 1076 M ACh being sucient to induce a
complete relaxation of endothelium-bearing preparations. As
predicted, in the endothelial-denuded preparations, ACh was
ineective independent of applied resting tension, while Na
nitroprusside was still able to relax aortic strips (not shown).
No dierences in the dose-response curve of ACh were
observed in relation to resting tension (Table 1). Moreover, in
the presence of an intact endothelium, the Na nitroprusside
relaxant eect was also not dierent in preparations stretched
at 0.7 g and 2.5 g (EC50s: 44.1+4.01 and 41.8+3.80 nM
respectively at 0.7 g and 2.5 g).
The role of NO-mediated relaxation dependent on the
activation of ecNOS at the dierent tensions was tested by
inhibiting the enzyme with 100 mM L-NAME (Figure 3). At
the lower resting tension, L-NAME (100 mM, 30 min
preincubation) did not reduce the endothelium-dependent
vasorelaxation induced by ACh (Figure 3A) and ACh EC50s
were not significantly dierent (Table 1). Similar results were
obtained by preincubating aortic strips with 200 mM L-
NAME for 60 min.
We also tested the eect of two other ecNOS inhibitors,
namely L-NMMA (100 mM, 60 min preincubation) and L-
NIO (25 mM, 60 min preincubation). As reported in Table
2, at low resting tension ACh EC50s were not significantly
dierent when they were calculated on the 1st curve
performed in the presence of the indicated ecNOS
inhibitor. However, by repeating ACh dose-response curves
several times on the same preparation maintained in a
continuous perfusion of ecNOS inhibitors, the ACh
relaxant eect decreased and on the 4th curve the ACh
EC50s were up to 4 fold higher than those calculated on
the 1st curve (Table 2).
When resting tension was set at 2.5 g, the preincubation
with 100 mM L-NAME for 30 min shifted the ACh dose-
response curve to the right (Figure 3B), as demonstrated by
the increase in ACh EC50s (Table 1). Similarly, the ACh
dose-response curve was shifted to the right after pre-
incubation with either 100 mM L-NMMA or 25 mM L-NIO
(Table 2). By repeating ACh dose-response curves several
times on the same preparation maintained in the constant
presence of ecNOS inhibitors, ACh, EC50s were increased,
Figure 1 Eect of phenylephrine on isolated rat thoracic aortic
strips. Cumulative dose-response curves of phenylephrine were
performed at 0.7, 1.2 and 2.5 g resting tension. Values are the
mean+s.e.mean of at least four experiments.
Figure 2 Eect of ACh on phenylephrine-precontracted rat aortic
strips. Cumulative dose-response curves of ACh were performed in
control conditions (A and B) and in the presence of 5 mM
indomethacin (C and D). Aortic strips were stretched at a resting
tension of 0.7 g (A and C panels) and 2.5 g (B and D) and
precontracted with 1077 M phenylephrine (Phe). Black squares
indicate ACh (1077 – 361077 – 1076 M) administration. Typical
traces are shown. W=washing.
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although these increases were of a lesser extent than those
observed at a lower resting tension (Table 2).
At an intermediate resting tension (1.2 g), the ACh EC50
calculated in the presence of 100 mM L-NAME was
significantly increased from 0.25+0.015 (control) to
0.49+0.012 mM (P50.001 vs control).
In order to better investigate the role of NO in the
vasorelaxant eect of ACh, we performed experiments using
either a guanylyl cyclase inhibitor (LY83583) or a NO
trapping agent (PTIO). As shown in Figure 4, the inhibition
of guanylyl cyclase or the trapping of NO prevented the
vasorelaxant eect of ACh. LY83583 (10 mM) totally
abolished the vasorelaxation induced by ACh, whereas
10 mM PTIO blocked it by 96%. At high resting tension,
the ACh dose-response curve performed in the presence of L-
NAME was not modified by co-incubation with either 10 mM
PTIO or 10 mM LY83583.
The role of COX metabolites in the vasorelaxation induced
by ACh was then investigated by blocking COX isoenzymes
with 5 mM indomethacin. In these conditions (pre-incubation
with 5 mM indomethacin for 30 min), the contractile eect of
phenylephrine was not modified at the assayed resting
tensions. ACh dose-dependently relaxed phenylephrine-pre-
contracted aortic strips only when resting tension was set at
2.5 g (Figure 2D). At the lower tension, ACh induced a
strong, long-lasting dose-dependent contraction (Figure 2C).
This increase in contraction was up to 2 fold the
phenylephrine-induced one at 1076 M ACh. Simultaneous
incubation with 5 mM indomethacin and 100 mM L-NAME
did not modify the contractile dose-response curve of ACh.
When preparations were stretched at 0.7 g and incubated
with ibuprofen (200 and 10 mM), another well known COX-
inhibitor avoiding lipoxygenase cross-inhibition, 1076 M ACh
induced a dose-dependent vasoconstriction. In this condition,
1076 M ACh induced an increase in contraction twice as
much as phenylephrine alone (206+19.3% and 203+6.2% in
the presence of 200 and 10 mM ibuprofen respectively). When
aortic strips were stretched at an intermediate resting tension
(1.2 g) and in the presence of 5 mM indomethacin, ACh also
induced a strong contraction; 1076 M ACh was able to
increase up to twice as much as phenylephrine alone
(197+22%). The ACh contractile eect observed in the
Table 1 Acetylcholine median eective concentrations
(EC50s) that induce relaxation in 10
77
M phenylephrine-
precontracted rat aortic strips
EC50 (mM)
Resting tension
0.7 g 2.5 g
Control 0.25+0.024 0.25+0.017
(5) (8)
100 mM L-NAME 0.28+0.017 0.85+0.09*
(5) (8)
Values are the mean+s.e.mean of the number of experiments
in brackets. *P50.001 vs control.
Figure 3 Eect of L-NAME on ACh-induced relaxation. Cumulative dose-response curves of ACh either in control conditions or
after 30 min preincubation with 100 mM L-NAME were performed on 1077 M phenylephrine-precontracted rat thoracic aortic strips
stretched at dierent resting tensions (A: 0.7 g and B: 2.5 g). The contraction obtained after phenylephrine is set as 100%. Values
are the mean+s.e.mean of at least four experiments.
Table 2 Acetylcholine median eective concentrations (EC50s) that relax phenylephrine-precontracted rat aortic strips calculated on
the 1st and 4th repeated curve
EC50 (mM)
Resting tension
0.7 g 2.5 g
1st 4th 1st 4th
Control 0.26+0.022 0.27+0.028 0.25+0.017 0.27+0.028
25 mM L-NIO 0.28+0.030 1.12+0.187*,** 0.81+0.075* 1.10+0.123*,**
100 mM L-MMA 0.26+0.025 1.14+0.147*,** 0.73+0.012* 0.91+0.082*,**
ACh dose-response curves were repeatedly performed on 1077 M phenylephrine-precontracted rat aortic strips after washing in the
continuous presence of the indicated ecNOS inhibitor. For more details, see Methods. Values are the mean+s.e.mean of at least three
experiments. *P50.001 vs control, **P50.001 vs 1st curve of same treatment.
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presence of COX inhibitors was, however, absent when
endothelium was mechanically removed. In the absence of
endothelium, 1074 M ACh was also unable to induce
contraction or relaxation in either the presence or absence
of indomethacin.
When aortic strips were precontracted with the maximal
contracting dose of PGF2a (10
75 M), ACh induced a dose-
dependent relaxation independent of resting tension (Figure
5A and B). When preparations were stretched at 0.7 g and
preincubated with 5 mM indomethacin, ACh induced a dose-
dependent contraction (Figure 5C), while when resting
tension was at 2.5 g, ACh also induced relaxation in the
presence of indomethacin.
In order to explore the nature of contractile agents released
by endothelium in the presence of 5 mM indomethacin at 0.7 g
resting tension, the eects of two lipoxygenase inhibitors were
tested. Both ETI (20 mM) and MK-886 (1 mM) antagonized
the contractile eect of 1076 M ACh (Table 3), but did not
restore its relaxant eect. Similarly, at a very high dose,
indomethacin (100 mM) prevented the contractile eect of
1076 M ACh observed in its presence at a low dosage (5 mM
indomethacin), and the administration of ACh did not
modify the contracting tone induced by phenylephrine.
Moreover, since the increase in contraction may be
dependent on the calcium influx through the L-type calcium
channel, we tested the eect of the L-type calcium channel
blocker verapamil (1 mM) on the extra contraction induced by
ACh in the presence of indomethacin. While the contractile
eect of phenylephrine was not influenced by 1 mM
verapamil, it prevented the contractile eect of ACh (Table
3). Lipoxygenase inhibitors also blocked the ACh-induced
extra contraction when resting tension was 1.2 g.
In a PGF2a precontracted preparation, preincubation with
100 mM indomethacin also abolished the extra contraction
induced by ACh at 0.7 g resting tension.
We then evaluated the eect of a simultaneous inhibition
of COX and NO-dependent relaxation. When resting tension
was set to 0.7 g, and 10 mM PTIO and 5 mM indomethacin
were simultaneously perfused, the ACh contractile dose-
response curve was only marginally modified, having ACh
EC50s not significantly dierent (0.41+0.13 mM, indometha-
cin alone vs 0.35+0.14 mM, indomethacin plus PTIO). When
resting tension was set to 1.2 g, the ACh dose-response curve
was shifted to the left by pre-incubating with 5 mM
indomethacin and 100 mM L-NAME; however, 361077 M
ACh induced the maximal contraction. When resting tension
was set to 2.5 g, the simultaneous perfusion of 5 mM
indomethacin and 100 mM L-NAME totally prevented the
relaxant eect of ACh. Still, ACh did not induce a significant
increase in contractions (not shown).
PGI2 release
We also measured the release of PGI2 in the organ bath by
measuring its main metabolite 6-keto PGF1a at the lower
resting tension. As shown in Figure 6, after the administra-
tion of phenylephrine, a significant increase in PGI2 was
observed. The successive administration of ACh was unable
to further increase the release of PGI2 in the organ bath.
After washing ACh and phenylephrine, the same aortic strips
were preincubated with 5 mM indomethacin. As predicted,
indomethacin strongly reduced the production of PGI2. Nor
the consecutive administration of phenylephrine and ACh,
nor preincubation with ETI restored the release measured in
control conditions.
Discussion
Our data show new aspects of the endothelial-mediated
regulation of rat aorta tone primarily dependent on resting
tension.
When resting tension is low (0.7 g), COX-derived metabo-
lites, synergistically with NO, seem to play an important role
in the relaxation induced by ACh. In these experimental
conditions, a stored pool of NO is released, while NO neo-
synthesis is practically absent. Indeed, although ecNOS
inhibitors, namely L-NAME, L-NMMA and L-NIO, do not
modify the dose-response curve of ACh, LY83583 abolishes
ACh-induced relaxation of phenylephrine-precontracted aor-
tic strips, indicating a relevant role for guanylyl cyclase.
Moreover, the finding that PTIO strongly reduces ACh-
induced relaxation suggests that ACh can mobilize a stored
NO pool, which, synergistically with PGI2, can relax
precontracted strips. This stored NO pool is, however,
limited. Indeed, by repeating the ACh dose-response curve
several times in the continuous presence of ecNOS inhibitors,
Figure 4 Eect of LY83583 and PTIO on ACh-induced relaxation.
Cumulative dose-response curves of ACh in control conditions, after
30 min preincubation with either 10 mM LY83583 or 10 mM PTIO
were performed on 1077 M phenylephrine-precontracted rat thoracic
aortic strips stretched at 0.7 g resting tension. The contraction
obtained after phenylephrine is set as 100%. Values are the
mean+s.e.mean of at least four experiments.
Figure 5 Eect of ACh on PGF2a-precontracted rat aortic strips.
Cumulative dose-response curves of ACh were performed in control
conditions (A and B) and in the presence of 5 mM indomethacin (C
and D). Aortic strips were stretched at a resting tension of 0.7 g (A
and C) and 2.5 g (B and D) and precontracted with 1075 M PGF2a
(PGF2a). Black squares indicate ACh (10
77 – 361077 – 1076 M)
administration. Typical traces are shown. W=washing.
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the relaxing eect of ACh is strongly reduced as demon-
strated by the powerful increase in ACh EC50s. A similar
stored nitric oxide pool has been described in rabbit aortic
smooth muscle (Venturini et al., 1993), rat aortic non-
endothelial cells when the aorta is treated for 18 h with LPS
and L-Arginine (Muller et al., 1996), in vivo in L-NAME
treated rats (Davisson et al., 1996) and, more recently, in
human platelets (Hirayama et al., 1999). The exact biological
meaning of this pool is still unclear, but according to our
data, it can be hypothesized that it plays a role when stretch
is low. In vivo this condition may be mimicked when blood
pressure is low and cells of resistance vessels are marginally
stretched. In this condition, NO can be supplied without a
constant ecNOS activation. Moreover, as judged by the data
obtained in the presence of LY83583, it seems that guanylyl
cyclase activation is the main relaxant pathway in rat aortic
preparations stretched at low resting tension.
The dosage of PGI2 through its metabolite 6-keto PGF1a
shows that a consistent PGI2 amount is released immediately
after phenylephrine administration. The subsequent adminis-
tration of ACh is unable to achieve a further increase in PGI2
production in the perfusion medium. As expected, in the
presence of 5 mM indomethacin, the production of PGI2 is
strongly inhibited and the small trend to a further decrease in
PGI2 can probably be attributed to the washing of small
quantities of either PGI2 or its metabolites trapped inside
cells and tissue.
On the other hand, as shown in Figures 1 and 2,
phenylephrine induces a consistent contraction, which is only
marginally aected by COX inhibition. Therefore, the self-
produced PGI2 is incapable of inducing a relevant relaxation.
However, this self-produced PGI2 seems to be essential, since,
at low resting tension, relaxation disappears in the presence
of COX inhibitors and it is not restored also when the ACh-
induced extra contraction is prevented (see below).
Thus at low stretch, ACh can induce a release of stored
NO, which synergistically with self-produced PGI2 induces
relaxation. A synergistic antiaggregatory eect of PGI2 and
NO has been originally described in human platelets: low
doses of both compounds inhibit aggregation and induce
disaggregation of human platelets, while either PGI2 or NO
alone at the same dose are ineective (Radomski et al., 1987).
Our data also show that at a lower resting tensions (0.7 g
and 1.2 g), when COX metabolism is inhibited, ACh strongly
contracts phenylephrine-precontracted vessels. In this condi-
tion, the arachidonic acid metabolic pathway through
lipoxygenase can predominate and lipoxygenase-derived
contracting factors account for this paradoxical eect of
ACh. Although we are unable to measure by radioimmu-
noassay an in-the-range leukotriene amount (D4, C4 and E4
leukotrienes, that, according to Ka¨hler et al. (1993), can be
synthesized by bovine aortic endothelial cells), the finding
that lipoxygenase inhibitors block the ACh-induced extra
contraction strongly suggests this hypothesis. Also, the
suppression of ACh-induced contraction by 100 mM indo-
methacin is in line with this interpretation: the high dose of
indomethacin can also inhibit lipoxygenase (Siegel et al.,
1979). Moreover, since MK-886 is a specific inhibitor of 5-
lipoxygenase (Gillard et al., 1989), this isoform plays a major
role in our preparations. A similar diversion of arachidonic
acid to the lipoxygenase pathway has been observed in canine
saphenous veins: the maximal contraction evoked by ACh
and high extracellular potassium concentration (Rimele &
Vanhoutte, 1983) and bradykinin (Marsault et al., 1997) is
enhanced in the presence of indomethacin in comparison to
that obtained in control conditions. Since in all cases the
control contraction is restored in the presence of indometha-
cin and nordihydroguaiaretic acid, an inhibitor of lipoxygen-
ase, it has been argued that the inhibition of COX, turning
arachidonic acid metabolism to lipoxygenase, produces
lipoxygenase vasoconstrictor metabolites (Rimele & Van-
houtte, 1983; Marsault et al., 1997). Lipoxygenase metabo-
lites could increase intracellular calcium by directly activating
voltage-sensitive calcium channels (Vanhoutte et al., 1985).
Indeed, in canine saphenous veins, diltiazem inhibits the
increase in tension due to indomethacin preincubation during
ACh- and potassium-induced contractions (Rimile & Van-
houtte, 1983).
In our experiments, verapamil prevents the ACh-induced
contraction, suggesting that the paradoxical eect of ACh
(observed at low resting tension in the presence of 5 mM
indomethacin and blocked by lipoxygenase inhibitors) is
mediated by an influx of extracellular calcium through L-
type, voltage-dependent calcium channels. Therefore, a
Table 3 Eect of 1076 M acetylcholine on rat aortic strips preincubated with 5 mM indomethacin in the absence (none) or presence of
lipoxygenase inhibitors or verapamil
% of contraction
None 20 mM ETI 1 mM MK-886 100 mM Indomethacin 1 mM Verapamil
202+20 119+6* 113+6.7* 115+7.5* 100+3.5*
*P50.001 vs no lipoxygenase inhibitors (None). Rat aortic strips were precontracted with 1077 M phenylephrine and preincubated with
5 mM indomethacin (30 min, 378C) in the absence (None) or presence of either lipoxygenase inhibitors of verapamil. Contractile force
developed by 1077 M phenylephrine was set as 100%. Values are the mean+s.e.mean of at least four experiments. Experiments were
performed at 0.7 g resting tension.
Figure 6 Release of 6-keto PGF1a from isolated rat aortic strips. 6-
keto PGF1a was measured by RIA either under basal conditions, after
administration of 1077 M phenylephrine or after administration of
1077 M phenylephrine and 1076 M ACh on the supernatant obtained
from the same isolated rat thoracic aortic strips preloaded at 0.7 g.
Basal value indicates the level of 6-keto PGF1a after reaching a steady-
state tension in each experimental condition. For more details, see
Methods. Values are the mean+s.e.mean of four experiments.
*P50.001 vs basal conditions; }P50.001 vs control.
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relevant target for lipoxygenase products can be L-type
calcium channels. Since the ACh contractile eect is
abolished in the absence of endothelium, the contractile
lipoxygenase metabolite(s) seem(s) to be produced by
endothelial cells.
At high resting tension, the NO pathway predominates and
COX metabolites seem to influence ACh-induced relaxation
only marginally. Indeed, indomethacin does not modify the
relaxant eect of ACh, while L-NAME, L-NMMA and L-
NIO do. These data suggest that the ‘de novo’ synthesis of
NO is mainly responsible for ACh-induced relaxation when a
high resting tension is applied. Indeed, the inhibition of
guanylyl cyclase by LY83583 or NO trapping by PTIO does
not potentiate the L-NAME inhibitory eect. Moreover, by
repeating the ACh dose-response curve on the same
preparation in the continuous presence of ecNOS inhibitors,
the ACh EC50s are increased, but these increases are quite
limited.
The residual relaxation obtained at high ACh doses
(1076 M) in the presence of L-NAME is prevented by 5 mM
indomethacin, but ACh never induces contractions. This
result suggests that the lipoxygenase products responsible for
ACh-induced contractions are either not produced or the
mechanism controlling the contractions is inactivated.
At an intermediate tension (1.2 g), the ACh dose-response
curve performed in the presence of the ecNOS inhibitor L-
NAME is shifted to the right, as shown when preparations
are stretched at high resting tension. However, in the presence
of 5 mM indomethacin, ACh strongly contracted aortic strips
and the preparations behave as those stretched at low resting
tension. Therefore, although we do not explore a linear range
of resting tensions, it seems that the stretch-dependent
behaviour of aortic preparations modifies gradually.
These stretch-dependent behaviours are not dependent on a
dierent sensitivity to NO, since Na nitroprusside relaxation
is not influenced by resting tension.
Mechanical stretch and/or swelling can activate ionic
channel activity in endothelial and smooth muscle cells
(Davis et al., 1992; Sackin, 1995). In cultured pig aortic
endothelial cells, stretch can activate calcium channels
(Lansman, 1987) and large-conductance, calcium-activated
K+ channels in freshly isolated smooth muscle cells from
rabbit mesenteric artery (Dopico et al., 1994). These
alterations in ion channel activity could modify resting
membrane potential and, therefore, modify the L-type,
voltage-dependent calcium channel properties, that, as
shown, seem to play a role in the lipoxygenase-dependent
contraction. Further research is needed to clarify this point.
In airway epithelium cells, cyclic stretch inhibits COX
metabolite synthesis (mainly PGE2, 6-keto PGF1a and TxB2)
(Savla et al., 1997), and mechanical stretch due to osmotic
swelling increases intracellular calcium concentration in
isolated human umbilical cord vein endothelial cells (Oike
et al., 1994). This increase in intracellular calcium concentra-
tion is blocked by 4-bromophenacylbromide, a PLA2
inhibitor, suggesting that the increase in intracellular calcium
is mediated by arachidonic acid (Oike et al., 1994). These
data, obtained in very dierent experiment conditions, imply
that stretch can modulate the arachidonic acid metabolism.
In conclusion, our data demonstrate that the synthesis,
release and eect of dierent endothelial-derived vasoactive
factors (namely NO, PGI2 and lipoxygenase metabolites) are
strictly linked to the stretch status of the aorta. All these
components may be relevant in the pathophysiological
regulation of blood pressure.
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